A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery
NCT05754333 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 107
Last updated 2025-10-09
Summary
The ureter was the tube that carries urine from the kidneys to the bladder. It was difficult for surgeons to see the ureter during abdominal surgery. This could lead to injuring the ureter which, although rare, could be serious. This study was about a potential new medical dye, called ASP5354. This dye was injected into the person at the start of surgery and was detected in the ureter. This was done by an imaging machine which had an option called near infrared fluorescence, or NIR-F. Together they showed live images of specific parts of the body. In this study, ASP5354 was used with an imaging machine with a NIR-F option to show live images of the ureter during surgery. People with kidneys that work properly and those with kidney problems could take part. The main aim of the study was to find out how clearly the ureter could be seen with ASP5354 during surgery in adults whose kidneys work properly or who have mild kidney problems. To do this, the surgeons injected ASP5354 into the person having surgery. Then, the surgeons compared images of the ureter with an imaging machine using normal white light and with the NIR-F option. Imaging using normal white light was the standard way surgeons see the ureter during surgery. People 12 years or older who were going to have certain abdominal surgeries could take part. Everyone taking part received ASP5354 during surgery, but how the imaging was done depended on which group they are in. Before surgery, the adults taking part whose kidneys work properly or who have mild kidney problems were assigned into 1 of 2 groups by chance alone. Images of the ureter were checked in 1 group using normal white light and the other group using normal white light and NIR-F. People 18 years and older with more severe kidney problems and all people under 18 years old were not be assigned to 1 of 2 groups: all images of the ureter were checked using normal white light and NIR-F. At the start of surgery, the surgeon injected ASP5354 into the person having surgery, then started recording a video. Then, after 30 minutes, the surgeon recorded how well the ureter could be seen. This was done by either using normal white light, or normal white light and NIR-F, depending which group each person having surgery was assigned to. For the group to be checked with normal white light and NIR-F, the surgeon did this every 30 minutes until the end of surgery. For the group to be checked with normal white light only, the surgeon did this after the first 30 minutes. During the study, people visited the study hospital 3 times. The first visit was to check if they can take part in the study. People were asked about their medical history, have had a medical examination, and their vital signs checked (blood pressure and pulse rate). Also, they had some blood and urine tests. For women and girls this may included a pregnancy test. People had their surgery at the second visit. This was within 28 days of their first visit. This included having some blood and urine tests before, during, and after surgery. Also, they had a medical examination, an electrocardiogram (ECG) to check their heart rhythm, and had their vital signs checked. After surgery, people returned to the clinic 15 days later for a final check-up. They were asked if they have had any medical problems. Also, they had a medical examination, had their vital signs checked, and had some blood and urine tests.
Conditions
- Intraoperative Ureter Visualization
- Abdominolpelvic Surgery
Interventions
- DRUG
-
pudexacianinium chloride
Intravenous
Sponsors & Collaborators
-
Astellas Pharma Global Development, Inc.
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Astellas Pharma Global Development, Inc.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-08-02
- Primary Completion
- 2024-12-17
- Completion
- 2025-01-16
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effects of Ephedrine, Phenylephrine, Norepinephrine and Vasopressin on Contractility of Human Myometrium and Umbilical Vessels: An In-vitro Study
NCT04053478 ·Status: RECRUITING ·Phase: NA
-
Detection of Preterm Labour by Cervical Length
NCT04104984 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Maternal and Perinatal Outcome in Women With History of Premature Labor in Previous Pregnancy
NCT01375439 ·Status: COMPLETED ·Phase: NA
-
Antepartum Chronic Epidural Therapy (ACET) to Improve Blood Flow to the Uterus, Placenta and Baby in Pre-Eclampsia and Intrauterine Growth Restriction
NCT00197340 ·Status: COMPLETED ·Phase: PHASE3
-
Uterine Contractions Under Blue Light
NCT03691740 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Early Amniotomy for Induction of Labor
NCT00133016 ·Status: WITHDRAWN ·Phase: NA
-
Comparison of Inhaled Oxytocin (IH) With Intramuscular (IM) Oxytocin in Pregnant Women and With Intravenous (IV) Oxytocin in Healthy Non-pregnant Women
NCT02999100 ·Status: TERMINATED ·Phase: PHASE1
-
IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage
NCT01608958 ·Status: COMPLETED ·Phase: NA
-
Noninvasive Monitoring of Uterine Activity and Fetal Heart Rate
NCT05782296 ·Status: COMPLETED
-
Investigating the Effect of Pulsatile Administration of Oxytocin on the Desensitization of Human Myometrium In-vitro
NCT02338089 ·Status: COMPLETED ·Phase: NA
-
The Effect of Dural Puncture Epidural Block Technique on the Effectiveness and Safety of Labor Analgesia
NCT05990504 ·Status: COMPLETED ·Phase: NA
-
Effect of Different Labour Analgesics on Maternal and Fetal Blood Flow Observed by Doppler Ultrasonography
NCT06099938 ·Status: COMPLETED
-
VPIA Remifentanil for Labour Pain to Reduce Maternal Desaturation and Improve Analgesic Titration
NCT02733835 ·Status: UNKNOWN ·Phase: PHASE4
-
In Vitro Evaluation of Spontaneous and Oxytocin-induced Contractility of Pregnant Human Myometrium During Exposure to Dexmedetomidine
NCT05511415 ·Status: COMPLETED ·Phase: NA
-
Injection Treatment of Corticosteroid to Pelvic Ligament Insertions on Women With Longlasting Backpain After Pregnancy
NCT00757016 ·Status: COMPLETED ·Phase: NA
-
Oxytocin and Fetal Heart Rate Changes
NCT03232918 ·Status: RECRUITING ·Phase: PHASE4
-
Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy
NCT02932319 ·Status: COMPLETED ·Phase: NA
-
Oxytocin Administration in the Third Stage of Labour - A Study of Appropriate Route and Dose
NCT00200252 ·Status: COMPLETED ·Phase: PHASE4
-
Pulse Pressure and Post-epidural Fetal Heart Rate Changes
NCT02565485 ·Status: COMPLETED ·Phase: NA
-
Indomethacin PK and PD Therapy in Pregnancy
NCT02451228 ·Status: COMPLETED
-
Changes in Velocimetric Indices of Uterine and Umbilical Arteries Before and After Combined Spinal-epidural Analgesia in Laboring Women (PART II)
NCT06655675 ·Status: RECRUITING ·Phase: NA
-
Ultrasound Predictors of Difficulty in Performing Epidural Anesthesia for Labor in Pregnant Patients.
NCT07056166 ·Status: RECRUITING
-
Navigating the Grey Zone for Antenatal Corticosteroids
NCT04792112 ·Status: UNKNOWN ·Phase: NA
-
Controlled Cord Traction During Third Stage of Labor
NCT00781066 ·Status: COMPLETED ·Phase: PHASE3
-
Breech Pelvimetry by EOS® Technique With Change of Maternal Position and Delivery Route
NCT05224908 ·Status: COMPLETED ·Phase: NA